Neurizon Therapeutics Limited

ASX:NUZ Stock Report

Market Cap: AU$80.3m

Neurizon Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:NUZ Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Nov 24BuyAU$50,000Michael ThurnIndividual263,158AU$0.19
01 Nov 24BuyAU$50,000Kathryn MacFarlaneIndividual263,158AU$0.19
01 Nov 24BuyAU$500,000Marcus HughesIndividual2,631,579AU$0.19
01 Nov 24BuyAU$250,000Sergio DuchiniIndividual1,315,789AU$0.19
23 Feb 24BuyAU$45,000Sam WrightIndividual450,000AU$0.10

Insider Trading Volume

Insider Buying: NUZ insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NUZ?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,263,2920.876%
Private Companies35,007,9057.19%
Individual Insiders105,922,88121.8%
General Public341,440,47770.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.1%.


Top Shareholders

Top 24 shareholders own 29.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.57%
Hybrid Holdings Pty Ltd
22,250,000AU$3.7m0%no data
3.8%
Gerald Van Blommestein
18,498,526AU$3.1m2.55%no data
3.09%
Roger Aston
15,044,815AU$2.5m0%no data
2.97%
Marcus Hughes
14,453,869AU$2.4m22.3%no data
1.67%
Loon Tan Chek
8,125,000AU$1.3m76.6%no data
1.54%
Robert Bishop
7,500,058AU$1.2m0%no data
1.1%
Joanne Hughes
5,363,158AU$884.9k0%no data
1.08%
Magee Holdings Pty Ltd
5,257,905AU$867.6k38.4%no data
1.03%
Patrick Mchale
5,000,000AU$825.0k0%no data
0.96%
Richard Reid
4,658,684AU$768.7k25.9%no data
0.88%
Douglas Kitchen
4,266,236AU$703.9k0.28%no data
0.88%
Wilson Asset Management (International) Pty Ltd.
4,263,292AU$703.4k0%0.01%
0.82%
Straight Lines Consulting Pty Ltd
4,000,000AU$660.0k0%no data
0.73%
Paul Denham
3,530,527AU$582.5k11.6%no data
0.72%
A & J Russell Investments Pty Limited
3,500,000AU$577.5k0%no data
0.72%
Claire Darcy
3,480,703AU$574.3k67.9%no data
0.72%
Denise Simpson
3,480,703AU$574.3k67.9%no data
0.71%
Roger Bowman
3,432,895AU$566.4k-1.92%no data
0.58%
Michael Thurn
2,821,053AU$465.5k10.3%no data
0.42%
Rodney Peter-adkins
2,031,354AU$335.2k-11.7%no data
0.42%
Anne-Marie Adkins
2,031,353AU$335.2k-11.7%no data
0.27%
Sergio Duchini
1,315,789AU$217.1k0%no data
0.13%
John Clark
625,000AU$103.1k0%no data
0.054%
Kathryn MacFarlane
263,158AU$43.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 19:33
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neurizon Therapeutics Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stefan TanSpark Plus Pte Ltd